M Ogawa Selected Research

M Ogawa Research Topics

Disease

32	Neoplasms (Cancer) 03/2005 - 01/2000
9	Pancreatic Neoplasms (Pancreatic Cancer) 12/2005 - 05/2000
9	Carcinogenesis 11/2001 - 01/2000
8	Stomach Neoplasms (Stomach Cancer) 06/2015 - 07/2000
8	Carcinoma (Carcinomatosis) 01/2003 - 01/2000
7	Hepatocellular Carcinoma (Hepatoma) 03/2003 - 05/2000
7	Myocardial Infarction 09/2002 - 01/2000
6	Infections 06/2013 - 03/2000
6	Neoplasm Metastasis (Metastasis) 06/2003 - 11/2000
6	Colorectal Neoplasms (Colorectal Cancer) 03/2003 - 01/2000
5	Inflammation (Inflammations) 09/2018 - 01/2000
5	Breast Neoplasms (Breast Cancer) 07/2015 - 01/2000
5	Colonic Neoplasms (Colon Cancer) 11/2001 - 07/2000
4	Lymphoma (Lymphomas) 01/2021 - 10/2001
4	Pathologic Constriction (Stenosis) 10/2015 - 02/2000
4	Pancreatitis 11/2001 - 08/2000
4	Reperfusion Injury 12/2000 - 01/2000
3	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2000
3	Body Weight (Weight, Body) 06/2016 - 03/2001
3	Neurologic Manifestations (Neurological Manifestations) 11/2015 - 06/2000
3	Hemorrhage 03/2007 - 08/2000
3	Alopecia (Baldness) 11/2006 - 05/2001
3	Wounds and Injuries (Trauma) 02/2005 - 10/2000
3	Fibrosis (Cirrhosis) 01/2005 - 07/2000
3	Leukopenia 11/2001 - 02/2001
3	Adenoma (Adenomas) 06/2001 - 01/2000
3	Ischemia 12/2000 - 01/2000
2	Disease Progression 09/2021 - 08/2017
2	Lymphatic Metastasis 10/2015 - 10/2001
2	Choriocarcinoma 07/2015 - 01/2012
2	Abdominal Aortic Aneurysm 08/2012 - 04/2011
2	Anemia 07/2010 - 02/2001
2	Ulcer 07/2009 - 01/2003
2	Hematoma 03/2007 - 07/2000
2	Ascites 01/2003 - 05/2000
2	Liver Failure 01/2003 - 10/2001
2	Abscess 01/2003 - 03/2000
2	Hyperplasia 07/2002 - 02/2000
2	Citrullinemia 12/2001 - 01/2001
2	Neutropenia 11/2001 - 10/2001
2	Muscular Dystrophies (Muscular Dystrophy) 10/2001 - 08/2001
2	Neoplasm Micrometastasis 09/2001 - 02/2001
2	Esophageal Neoplasms (Esophageal Cancer) 07/2001 - 03/2001

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 09/2018 - 01/2000
14	Proteins (Proteins, Gene)FDA Link 09/2021 - 01/2000
6	Messenger RNA (mRNA)IBA 01/2012 - 05/2000
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2001 - 01/2000
5	EnzymesIBA 11/2005 - 05/2000
4	Pharmaceutical PreparationsIBA 07/2015 - 09/2000
4	Complementary DNA (cDNA)IBA 06/2003 - 12/2000
4	AntigensIBA 05/2001 - 06/2000
3	Matrix Metalloproteinases (MMPs)IBA 08/2012 - 08/2000
3	Biological ProductsIBA 08/2012 - 12/2000
3	Immunoglobulin G (IgG)IBA 11/2005 - 08/2000
3	Interleukin-6 (Interleukin 6)IBA 01/2003 - 01/2000
3	Pancreatic Elastase (Elastase)IBA 11/2001 - 09/2000
3	Antineoplastic Agents (Antineoplastics)IBA 11/2001 - 05/2000
3	beta CateninIBA 11/2001 - 07/2000
3	Keratins (Keratin)IBA 09/2001 - 06/2000
3	Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA 07/2001 - 01/2000
3	Indicators and Reagents (Reagents)IBA 05/2001 - 01/2001
3	Carcinoembryonic AntigenIBA 02/2001 - 05/2000
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2001 - 12/2000
3	Chemotactic FactorsIBA 12/2000 - 01/2000
3	Dopamine (Intropin)FDA LinkGeneric 07/2000 - 01/2000
2	Insulin (Novolin)FDA Link 06/2016 - 03/2001
2	rebamipideIBA 07/2009 - 01/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2007 - 01/2001
2	Capsules (Microcapsules)IBA 03/2007 - 10/2001
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 02/2007 - 11/2001
2	Interleukin-8 (Interleukin 8)IBA 03/2005 - 03/2001
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2005 - 05/2000
2	Butyric Acid (Butanoic Acid)IBA 01/2003 - 11/2001
2	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2002 - 11/2001
2	CitrullineIBA 12/2001 - 01/2001
2	Fibrinogen (Factor I)FDA Link 11/2001 - 10/2000
2	TCF Transcription FactorsIBA 11/2001 - 07/2000
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2001 - 04/2000
2	AnthracyclinesIBA 11/2001 - 11/2001
2	Factor VII (Proconvertin)IBA 11/2001 - 10/2000
2	Thromboplastin (Tissue Factor)IBA 11/2001 - 10/2000
2	Hemoglobins (Hemoglobin)IBA 11/2001 - 11/2001
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2001 - 04/2000
2	Tumor Biomarkers (Tumor Markers)IBA 11/2001 - 09/2001
2	amrubicinIBA 11/2001 - 11/2001
2	Therapeutic UsesIBA 09/2001 - 03/2000
2	Genetic Markers (Genetic Marker)IBA 09/2001 - 02/2001
2	Biomarkers (Surrogate Marker)IBA 07/2001 - 01/2000
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2001 - 01/2001

Therapy/Procedure

17	Therapeutics 06/2013 - 01/2000
4	Drug Therapy (Chemotherapy) 01/2021 - 11/2000
4	Gastrectomy 01/2003 - 01/2001
4	Lymph Node Excision (Lymph Node Dissection) 01/2003 - 01/2001
3	Radiotherapy 10/2015 - 03/2001
3	Laparotomy 10/2001 - 11/2000
2	Ligation 03/2010 - 01/2001
2	Combination Drug Therapy (Combination Chemotherapy) 11/2001 - 02/2001
2	Thoracotomy 10/2001 - 03/2000
2	Radiofrequency Ablation 10/2001 - 05/2001
2	Liver Transplantation 09/2001 - 06/2000